US healthcare startup Aledade valued at $3.5 billion after funding led by Lightspeed Venture Partners

The round was led by Lightspeed Venture Partners and fetched $260 million for the Bethesda, Maryland-based startup, the company said in a statement.

ETtech
Aledade is a public benefit corporation in the US that works with primary care physicians, health centers and clinics to develop value-based healthcare programs (Illustration: Rahul Awasthi)
US healthcare startup Aledade was valued at $3.5 billion after its latest funding round, a source close to the company told Reuters on Wednesday.

The round was led by Lightspeed Venture Partners and fetched $260 million for the Bethesda, Maryland-based startup, the company said in a statement.

Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management & Research Company also participated in the fundraise.


Aledade is a public benefit corporation in the US that works with primary care physicians, health centers and clinics to develop value-based healthcare programs.

The startup generated more than $475 million in revenue for 2022, over 50% higher than the year before.

Earlier this year, Aledade and insurer Humana announced a 10-year collaboration to provide value-based primary care for Humana's Medicare Advantage members.
ADVERTISEMENT

Venture capital fundraising in the United States has started to pick up pace alongside a recovery in public markets, as economic worries eased on expectations that the Federal Reserve was done with the bulk of its rate hikes.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Tech › Funding › US healthcare startup Aledade valued at $3.5 billion after funding led by Lightspeed Venture Partners
Text Size:AAA
Success
This article has been saved

*

+